This article presents a study of the use of melatonin to treat sleep-wake-cycle disorders in 100 visually impaired children aged 3 months to 17 years. The study found that these disorders are correlated with the children's visual diagnoses, visual loss, age, associated disabilities, level of independence, and type of placement and that the use of oral melatonin ameliorates these disorders without side effects and leads to numerous benefits, both to the children and their caregivers.